Breaking News Instant updates and real-time market news.

ADMS

Adamas Pharmaceuticals

$16.82

-0.21 (-1.23%)

16:20
08/08/17
08/08
16:20
08/08/17
16:20

Adamas Pharmaceuticals reports Q2 EPS (93c), consensus (81c)

Reports Q2 revenue $2,000. The company said, "This is a very exciting time for Adamas, as we are potentially at the cusp of transitioning from a company focused on product development to a commercial entity marketing its own medicines. We look forward to hearing from the FDA regarding the potential approval of ADS-5102 for the treatment of levodopa-induced dyskinesia in people with Parkinson's disease. If approved, ADS-5102 will be the first and only approved medicine for this indication." The New Drug Application for ADS-5102 has a PDUFA date of August 24, 2017." Adamas ended the quarter with $144.9M of cash, cash equivalents, and available-for-sale securities.

  • 08

    Aug

  • 24

    Aug

ADMS Adamas Pharmaceuticals
$16.82

-0.21 (-1.23%)

11/23/16
JMPS
11/23/16
NO CHANGE
JMPS
Adamas could have positive read through from Allergan deal, says JMP Securities
After Adamas' partner, Allergan (AGN), agreed to buy Chase Pharmaceuticals, JMP Securities analyst Jason Butler thinks that the deal could have positive implications for Adamas Pharmaceuticals and its Alzheimer's treatment, Namzaric, a combination therapy which blocks a neutrotransmitter. The analyst says that the deal "reinforces Allergan's long-term commitment to neurotransmitter focused" Alzheimer;s treatments and provides the opportunity for Chase's drug to be combined with Namzaric. The analyst thinks that such a combined drug could gain additional market share. He keeps a $29 price target and an Outperform rating on Adamas.

TODAY'S FREE FLY STORIES

09:30
06/20/18
06/20
09:30
06/20/18
09:30
General news
The U.S. current account gap widened »

The U.S. current account…

VHC

VirnetX

$3.45

(0.00%)

09:29
06/20/18
06/20
09:29
06/20/18
09:29
Hot Stocks
VirnetX enters reseller agreement with Above PAR Advisors »

VirnetX has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$33.21

(0.00%)

, SRPT

Sarepta

$143.92

(0.00%)

09:27
06/20/18
06/20
09:27
06/20/18
09:27
Recommendations
PTC Therapeutics, Sarepta analyst commentary  »

PTC Therapeutics weakness…

PTCT

PTC Therapeutics

$33.21

(0.00%)

SRPT

Sarepta

$143.92

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

AMZN

Amazon.com

$1,735.74

(0.00%)

, BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Breaking Hot Stocks news story on Amazon.com, Berkshire Hathaway, Berkshire Hathaway, JPMorgan »

Amazon, Berkshire,…

AMZN

Amazon.com

$1,735.74

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

TLGT

Teligent

$3.70

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Teligent announces FDA approval of Fluocinonide Gel, 0.05% »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$207.24

(0.00%)

, TST

TheStreet

$1.78

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
S&P Global confirms purchase of RateWatch business from TheStreet »

S&P Global (SPGI)…

SPGI

S&P Global

$207.24

(0.00%)

TST

TheStreet

$1.78

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
06/20/18
06/20
09:25
06/20/18
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD topped…

AZZ

AZZ Inc.

$44.93

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Energy Subcommittee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTEX

Mannatech

$20.40

(0.00%)

09:24
06/20/18
06/20
09:24
06/20/18
09:24
Hot Stocks
Mannatech announces final results of modified Dutch auction tender offer »

Mannatech announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$127.56

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Hot Stocks
Starbucks CEO says 'some canibalization,' new entrants hurt China SSS in Q3 »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EMCI

EMC Insurance

$27.28

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Upgrade
EMC Insurance rating change  »

EMC Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$10.00

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Syndicate
Kindred Biosciences 4.632M share Spot Secondary priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

RUT

Russell 2000 Index

$0.00

(0.00%)

, IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

09:20
06/20/18
06/20
09:20
06/20/18
09:20
Technical Analysis
Technical Take: iShares Trust Russell 2000 Index Fund hits new life high »

In pre-market trading the…

RUT

Russell 2000 Index

$0.00

(0.00%)

IWM

iShares Trust Russell 2000 Index Fund

$168.64

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:19
06/20/18
06/20
09:19
06/20/18
09:19
Hot Stocks
Starbucks CEO sees transitioning to 'growth at scale' phase »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

FEYE

FireEye

$16.99

(0.00%)

09:19
06/20/18
06/20
09:19
06/20/18
09:19
Hot Stocks
FireEye and Gigamon partner in security services »

FireEye and Gigamon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

TST

TheStreet

$1.78

(0.00%)

, SPGI

S&P Global

$207.24

(0.00%)

09:18
06/20/18
06/20
09:18
06/20/18
09:18
Hot Stocks
TheStreet sells RateWatch business to S&P Global for $33.5M »

TheStreet (TST) announced…

TST

TheStreet

$1.78

(0.00%)

SPGI

S&P Global

$207.24

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
06/20/18
06/20
09:18
06/20/18
09:18
Options
Overnight activity included 221 trades in SPX and 10 trades in VIX »

221 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

(0.00%)

09:16
06/20/18
06/20
09:16
06/20/18
09:16
Recommendations
Oracle analyst commentary  »

Oracle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.60

(0.00%)

09:16
06/20/18
06/20
09:16
06/20/18
09:16
Conference/Events
The Executives' Club of Chicago to hold a meeting »

The Executives Club of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

09:15
06/20/18
06/20
09:15
06/20/18
09:15
General news
Breaking General news story  »

Speech to be released at…

09:13
06/20/18
06/20
09:13
06/20/18
09:13
Conference/Events
Senate Finance Committee to hold a hearing »

The Committee holds a…

RSLS

ReShape Lifesciences

$3.19

0.12 (3.91%)

09:13
06/20/18
06/20
09:13
06/20/18
09:13
Syndicate
ReShape Lifesciences announces $1.5M registered direct offering priced ATM »

ReShape Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:11
06/20/18
06/20
09:11
06/20/18
09:11
Conference/Events
Federal Reserve Chairman Powell participates in a panel discussion »

Federal Reserve Chair…

XOM

Exxon Mobil

$80.70

-0.11 (-0.14%)

, HES

Hess Corp.

$61.42

-0.2 (-0.32%)

09:10
06/20/18
06/20
09:10
06/20/18
09:10
Hot Stocks
Exxon Mobil makes eighth oil discovery offshore Guyana »

Exxon Mobil (XOM) said it…

XOM

Exxon Mobil

$80.70

-0.11 (-0.14%)

HES

Hess Corp.

$61.42

-0.2 (-0.32%)

CEO

CNOOC

$161.14

-3.355 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.